This HTML5 document contains 67 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n13https://global.dbpedia.org/id/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n17http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n11http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Testosterone_benzoate
rdf:type
dbo:Drug owl:Thing wikidata:Q8386 dbo:ChemicalSubstance n17:ChemicalObject
rdfs:label
Testosterone benzoate
rdfs:comment
Testosterone benzoate, or testosterone 17β-benzoate, also known as androst-4-en-17β-ol-3-one 17β-benzoate, is a synthetic, injected anabolic–androgenic steroid (AAS) and an androgen ester – specifically, the benzoate C17β ester of testosterone – which was never marketed. It is a prodrug of testosterone and, when administered via intramuscular injection, is associated with a long-lasting depot effect and extended duration of action. The drug was first described in 1936 and was the first androgen ester and ester of testosterone to be synthesized.
foaf:depiction
n11:Testosterone_benzoate.svg
dcterms:subject
dbc:Androstanes dbc:Androgens_and_anabolic_steroids dbc:Enones dbc:Testosterone_esters dbc:Benzoate_esters dbc:Abandoned_drugs dbc:Prodrugs
dbo:wikiPageID
52466037
dbo:wikiPageRevisionID
1097449285
dbo:wikiPageWikiLink
dbr:Depot_injection dbr:Anabolic–androgenic_steroid dbr:List_of_androgen_esters dbr:Intramuscular_injection dbc:Androgens_and_anabolic_steroids dbr:Injection_(medicine) dbr:Prodrug dbr:Benzoate dbr:Chemical_synthesis dbr:Synthetic_compound dbr:Testosterone_(medication) dbc:Enones dbc:Abandoned_drugs dbc:Prodrugs dbc:Benzoate_esters dbr:Ester dbc:Testosterone_esters dbr:Androgen_ester dbc:Androstanes dbr:Duration_of_action
owl:sameAs
n13:2YPmZ yago-res:Testosterone_benzoate wikidata:Q27256755
dbp:wikiPageUsesTemplate
dbt:Steroid-stub dbt:Drugbox dbt:Reflist dbt:Genito-urinary-drug-stub dbt:Androgen_receptor_modulators
dbo:thumbnail
n11:Testosterone_benzoate.svg?width=300
dbp:c
26
dbp:casNumber
2088
dbp:chemspiderid
91692
dbp:h
32
dbp:iupacName
[-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] benzoate
dbp:o
3
dbp:pubchem
101474
dbp:routesOfAdministration
dbr:Intramuscular_injection
dbp:smiles
C[C@]12CC[C@H]3[C@H]CCC5=CCCC[C@]35C
dbp:stdinchi
1
dbp:stdinchikey
RZJSCADWIWNGKI-IXKNJLPQSA-N
dbp:synonyms
Testosterone 17β-benzoate; Androst-4-en-17β-ol-3-one 17β-benzoate
dbp:unii
387187
dbp:width
250
dbo:abstract
Testosterone benzoate, or testosterone 17β-benzoate, also known as androst-4-en-17β-ol-3-one 17β-benzoate, is a synthetic, injected anabolic–androgenic steroid (AAS) and an androgen ester – specifically, the benzoate C17β ester of testosterone – which was never marketed. It is a prodrug of testosterone and, when administered via intramuscular injection, is associated with a long-lasting depot effect and extended duration of action. The drug was first described in 1936 and was the first androgen ester and ester of testosterone to be synthesized.
prov:wasDerivedFrom
wikipedia-en:Testosterone_benzoate?oldid=1097449285&ns=0
dbo:wikiPageLength
4255
dbo:casNumber
2088-71-3
dbo:fdaUniiCode
387187KT3E
dbo:pubchem
101474
foaf:isPrimaryTopicOf
wikipedia-en:Testosterone_benzoate